Sandoz Group AG (SDZ.SW)
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide.
67.36+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+44.3%
The outlook
Sandoz Group AG currently reads as leaning bullish based on buy — 2.5 avg of 16 analysts, above its 50- & 200-day averages, 76% of the way from its 52-week low to high, avg target +5% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 16 analysts
Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 16 analysts70.49average target+4.6% vs now
Now 67.36
Low 52.51High 81.22
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$29.15B
52-wk high
74.72
52-wk low
43.86
50-day avg
67.04
200-day avg
62.33
Trailing P/E
39.4